While all state Medicaid programs include GLP-1s prescribed for Type 2 diabetes, only 36 states cover at least one of the FDA-approved GLP-1s for obesity (Wegovy, Zepbound, or Saxenda)
Before committing to a treatment, it is worth understanding what these medications do and the nutritional gaps they create
Cell1998 Feb 20;92(4):573-85
It also provides microdosing options for both semaglutide and tirzepatide, allowing patients to start at ultra-low doses and titrate gradually
Earning GMP certification from NSF verifies that a manufacturing facility has the proper methods, equipment, facilities, and controls in place to produce dietary supplement products.
Further experimental exploration, clinical trials, case-control studies, and cohort studies are needed to validate the results